NCT06223594View on ClinicalTrials.gov

Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

July 22, 2025

Study Completion Date

July 22, 2025

Conditions
Acute Pancreatitis
Interventions
OTHER

Intravenous Fluid Therapy

Evaluate the safety and efficacy of the Dallas acute pancreatitis protocol(DAPP) order set on Acute pancreatitis(AP) patients receiving aggressive, goal-directed Intravenous fluid(IVF )therapy.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER